Manteia
Latest round
- Series B
Last raised
- Jan 2024
Total raised
- $31M
Investors
- 5
About Manteia
Based in Xiamen, China and established in 2017, Manteia is a medical company that provides medical systems for adaptive radiation therapy. As of 2023, the company has passed the US FDA, China NMPA Class III, European CE and Korean KFDA product registration certification. In 2023, it develops and launches MOZI-Online TPS, the first plan design system that supports multiple guided images (CBCT/CT/MR). The company's main products include AccuContour (an intelligent radiotherapy image workstation), Online ART-TPS (an adaptive radiotherapy system) and ARTCheck (a real-time adaptive radiotherapy plan QA system). In addition, AccuContour provides image analysis and radiomics tools. The company's products are used in clinical treatment and other fields. Its clients are the Mayo Clinic, the National Cancer Center & Proton Center (NCC) of Korea, Seoul National University Hospital (SNUH), Peking Union Medical College Hospital, and the General Hospital of the People's Liberation Army.
Who invested in Manteia
5 investors across 3 rounds
See all investors in Manteia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Manteia
Who invested in Manteia?
Manteia has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Manteia raised?
Manteia has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Manteia last raise money?
Manteia's most recent round on record is a Series B, in Jan 2024.
What does Manteia do?
Based in Xiamen, China and established in 2017, Manteia is a medical company that provides medical systems for adaptive radiation therapy.
Where is Manteia headquartered?
Manteia is headquartered in Xiamen, China.
Which VCs invest in companies like Manteia?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare it companies at Manteia's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like Manteia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.